Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bioanalytical Systems

Bioanalytical Systems
1974 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
BASI STOCK SYMBOL
2 INVESTMENTS
$4.01 SHARE PRICE (As of Monday Closing)
Description

Bioanalytical Systems Inc is a contract research organization which provides drug discovery and development services and analytical instruments. The company operates in two business segments namely contract research services and research products. The contract research services segment provides research and development support on a contract basis directly to pharmaceutical companies. In addition, it also includes services to screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions.

Website
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Commercial Services
Stock Exchange
NAS
Primary Office
  • 2701 Kent Ave
  • West Lafayette, IN 47906
  • United States

+1 (317) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bioanalytical Systems’s full profile, request a free trial.

Bioanalytical Systems Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.18 - $4.44 $42.1M $3.68 -$0.12 61.6K 10.5M

Bioanalytical Systems Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
30-Sep-2018
FY 2017
30-Sep-2017
FY 2016
30-Sep-2016
Enterprise Value 30,748 19,399 19,532 15,815
Revenue 37,816 26,346 24,242 20,441
EBITDA 2,026 1,895 2,963 (1,289)
Net Income (1,280) (194) 884 (3,230)
Total Assets 38,644 31,268 20,417 21,129
Total Debt 14,382 9,579 4,579 5,338
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bioanalytical Systems Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bioanalytical Systems‘s full profile, request access.

Request full access to PitchBook

Bioanalytical Systems Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SGS Corporation Geneva, Switzerland 00000 000000000000
000 Corporation Stafford, Australia 00000 00000 000000000000
0000000 000000000 Private Equity-Backed London, United Kingdom 0000 00.000 000000000 00.000
000000 Private Debt Financed NJ 0000 000.00 000000000 000.00
000 00000000 00000 Private Equity-Backed Washington, DC 000000000000
To view this company’s complete list of competitors, request access »

Bioanalytical Systems Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000 00000 01-May-2019 000000000000000000 00.000 BPO/Outsource Services 000000 0000000
Seventh Wave Laboratories 02-Jul-2018 Merger/Acquisition 000 Drug Discovery 0000 00000000
To view this company’s complete investment and acquisition history, request access »

Bioanalytical Systems Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000 00000 Drug Discovery Maryland Heights, MO 0000
To view this company’s complete subsidiary history, request access »

Bioanalytical Systems Executive Team (7)

Name Title Board
Seat
Contact
Info
Robert Leasure Chief Executive Officer & Board Member
Jill Blumhoff Chief Financial Officer & Chief Accounting Officer
Dawn Joseph Director, Business Development
Joe Flynn Chief Commercial Officer

3 Former Executives

You’re viewing 4 of 7 executives. Get the full list »

Bioanalytical Systems Board Members (3)

Name Representing Role Since Contact
Info
000000 0000000 Bioanalytical Systems Chief Executive Officer & Board Member 000 0000

2 Former Board Members

You’re viewing 1 of 3 board members. Get the full list »